- Report
- June 2025
- 100 Pages
United States
From €3093EUR$3,500USD£2,725GBP
- Report
- March 2025
- 200 Pages
United States
From €2200EUR$2,490USD£1,939GBP
- Report
- January 2025
- 120 Pages
United States
From €2200EUR$2,490USD£1,939GBP
- Report
- August 2025
- 121 Pages
United States
From €2253EUR$2,549USD£1,985GBP
€2650EUR$2,999USD£2,335GBP
- Report
- February 2025
- 146 Pages
Middle East
From €2253EUR$2,549USD£1,985GBP
€2650EUR$2,999USD£2,335GBP
- Report
- July 2025
- 250 Pages
North America
From €3419EUR$3,869USD£3,012GBP
- Report
- July 2025
- 250 Pages
Middle East, Africa
From €3419EUR$3,869USD£3,012GBP
- Report
- July 2025
- 250 Pages
Latin America
From €3419EUR$3,869USD£3,012GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3419EUR$3,869USD£3,012GBP
- Report
- July 2025
- 250 Pages
Europe
From €3419EUR$3,869USD£3,012GBP
- Report
- July 2025
- 250 Pages
North America
From €3419EUR$3,869USD£3,012GBP
- Report
- February 2025
- 103 Pages
Europe
From €5298EUR$5,995USD£4,667GBP
- Report
- February 2025
- 73 Pages
North America
From €5298EUR$5,995USD£4,667GBP
- Report
- October 2025
- 91 Pages
Middle East
From €4286EUR$4,850USD£3,776GBP
From €4286EUR$4,850USD£3,776GBP
- Report
- June 2025
- 92 Pages
Europe
From €3491EUR$3,950USD£3,075GBP
- Report
- June 2025
- 182 Pages
United States
From €5298EUR$5,995USD£4,667GBP
- Report
- May 2025
- 88 Pages
North America
From €2607EUR$2,950USD£2,297GBP
- Report
- May 2025
- 98 Pages
Europe
From €3049EUR$3,450USD£2,686GBP
- Report
- May 2025
- 95 Pages
Asia Pacific
From €3049EUR$3,450USD£2,686GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more